|
PPT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.371400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.244400E-04 |
| Normal-vs-Stage2 |
1.169620E-01 |
| Normal-vs-Stage3 |
9.296000E-01 |
| Normal-vs-Stage4 |
4.813600E-01 |
| Stage1-vs-Stage2 |
9.841200E-01 |
| Stage1-vs-Stage3 |
2.924000E-02 |
| Stage1-vs-Stage4 |
7.666000E-02 |
| Stage2-vs-Stage3 |
1.385150E-01 |
| Stage2-vs-Stage4 |
1.575190E-01 |
| Stage3-vs-Stage4 |
7.402800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.19000000000391E-05 |
| Normal-vs-AfricanAmerican |
1.063970E-01 |
| Normal-vs-Asian |
4.653700E-02 |
| Caucasian-vs-AfricanAmerican |
6.799900E-02 |
| Caucasian-vs-Asian |
4.220200E-02 |
| AfricanAmerican-vs-Asian |
7.251700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99493999999412E-05 |
| Normal-vs-Female |
1.899810E-01 |
| Male-vs-Female |
3.303900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.522200E-01 |
| Normal-vs-Extreme_Weight |
1.022400E-03 |
| Normal-vs-Obese |
1.486140E-02 |
| Normal-vs-Extreme_Obese |
2.588200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.120500E-02 |
| Normal_Weight-vs-Obese |
1.071580E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.033400E-01 |
| Extreme_Weight-vs-Obese |
5.789400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.370600E-01 |
| Obese-vs-Extreme_Obese |
8.477200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.612800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.590980E-04 |
| Normal-vs-Age(61-80Yrs) |
8.598500E-04 |
| Normal-vs-Age(81-100Yrs) |
9.264000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.881900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.171630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.138200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.025600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.343420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.899160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.80100379054693E-11 |
| Normal-VS-Type2 PRCC |
1.142640E-01 |
| Normal-VS-KIRP CIMP |
1.97089999999234E-05 |
| Normal-VS-Unclassified PRCC |
5.067500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.99280649946377E-15 |
| Type1 PRCC-VS-KIRP CIMP |
2.03990002667354E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.618130E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.435120E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.801100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.78559999997052E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.400220E-01 |
| Normal-vs-N1 |
7.725500E-02 |
| Normal-vs-N2 |
5.620400E-03 |
| N0-vs-N1 |
1.058080E-02 |
| N0-vs-N2 |
9.989600E-02 |
| N1-vs-N2 |
2.682400E-01 |
|
|
